Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kohli, H.S., Bhat, A., Aravindan, et al. Spectrum of renal failure in elderly patients. Int. Urol. Nephrol. 2007; 23:23.
Hauer, H.A., Bajema, I.M., van Houwelingen, H.C., et al. Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups. Kidney Int. 2002; 61:80–89.
Ulm, S., Hummel, M., Emig, M., et al. Leukocytoclastic vasculitis and acute renal failure after influenza vaccination in an elderly patient with myelodysplastic syndrome. Onkologie 2006; 29:470–472. Epub 2006 Sep 27.
Jennette, J.C., Falk, R.J., Andrassy, K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994; 37:187–192.
Muller, E., Schneider, W., Kettritz, U., Schmidt, W.A., Luft, F.C., Gobel, U. Temporal arteritis with pauci-immune glomerulonephritis: A systemic disease. Clin. Nephrol. 2004; 62:384–386.
Jayne, D.R., Marshall, P.D., Jones, S.J., Lockwood, C.M. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990; 37:965–970.
Eisenberger, U., Fakhouri, F., Vanhille, P., et al. ANCA-negative pauci-immune renal vasculitis: Histology and outcome. Nephrol. Dial. Transplant 2005; 20: 1392–1399. Epub 2005 Apr 26.
Watts, R.A., Scott, D.G. Epidemiology of the vasculitides. Sem. Respir. Crit. Care Med. 2004; 25:455–464.
Krafcik, S.S., Covin, R.B., Lynch, J.P., III, Sitrin, R.G. Wegener’s granulomatosis in the elderly. Chest 1996; 109:430–437.
Vassallo, M., Shepherd, R.J., Iqbal, P., Feehally, I. Age-related variations in presentation and outcome in Wegener’s granulomatosis. J. Roy. Coll. Phys. Lond. 1997; 31:396–400.
Rychlik, I., Jancova, E., Tesar, V., et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol. Dial. Transplant 2004; 19:3040–3049. Epub 2004 Oct 26.
Hewins, P., Savage, C.O. ANCA and neutrophil biology. Kidney Blood Press. Res. 2003; 26:221–225.
Xiao, H., Heeringa, P., Hu, P., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 2002; 110:955–963.
Wang, Y., Zhao, M.H., Yu, J., et al. The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitis. Exp. Gerontol. 2004; 39:1401–1405.
Abdulahad, W.H., van der Geld, Y.M., Stegeman, C.A., Kallenberg, C.G. Persistent expansion of CD4+ effector memory T cells in Wegener’s granulomatosis. Kidney Int. 2006; 70:938–947. Epub 2006 Jul 12.
Birck, R., Warnatz, K., Lorenz, H.M., et al. 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: A six-month open-label trial to evaluate safety and efficacy. J. Am. Soc. Nephrol. 2003; 14:440–447.
Frampton, G., Jayne, D.R., Perry, G.J., Lockwood, C.M., Cameron, J.S. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin. Exp. Immunol. 1990; 82:227–232.
Booth, A.D., Almond, M.K., Burns, A., et al. Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am. J. Kidney Dis. 2003; 41:776–784.
Harper, L., Savage, C.O. ANCA-associated renal vasculitis at the end of the twentieth century—A disease of older patients. Rheumatology (Oxford) 2005; 44:495–501. Epub 2004 Dec 21.
Hauer, H.A., Bajema, I.M., Van Houwelingen, H.C., et al. Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002; 62:1732–1742.
Merkel, P.A., Seo, P., Aries, P., et al. Current status of outcome measures in vasculitis: Focus on Wegener’s granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J. Rheumatol. 2005; 32:2488–2495.
De Groot, K., Rasmussen, N., Bacon, P.A., et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005; 52:2461–2469.
Jayne, D., Rasmussen, N., Andrassy, K., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N. Engl. J. Med. 2003; 349:36–44.
Le Thi Huong, D., Wechsler, B., Piette, J.C., et al. [Wegener’s granulomatosis in elderly subjects. 37 cases.] [in French] Presse Med. 1988; 17:2379–2382.
Nada, A.K., Torres, V.E., Ryu, J.H., Lie, J.T., Holley, K.E. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin. Proc. 1990; 65:847–856.
Jayne, D.R., Rasmussen, N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin. Proc. 1997; 72:737–747.
de Groot, K., Adu, D., Savage, C.O. The value of pulse cyclophosphamide in ANCA-associated vasculitis: Meta-analysis and critical review. Nephrol. Dial. Transplant 2001; 16:2018–2027.
Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., et al. Wegener granulomatosis: An analysis of 158 patients. Ann. Intern. Med. 1992; 116:488–498.
Haubitz, M., Bohnenstengel, F., Brunkhorst, R., Schwab, M., Hofmann, U., Busse, D. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. Kidney Int. 2002; 61:1495–1501.
Pusey, C.D., Rees, A.J., Evans, D.J., Peters, D.K., Lockwood, C.M. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 1991; 40:757–763.
Boomsma, M.M., Stegeman, C.A., van der Leij, M.J., et al. Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study. Arthritis Rheum. 2000; 43:2025–2033.
Sanders, J.S., Huitma, M.G., Kallenberg, C.G., Stegeman, C.A. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 2006; 45:724–729. Epub 2006 Jan 6.
Jayne, D.R., Chapel, H., Adu, D., et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Quar. J. Med. 2000; 93:433–439.
Ito-Ihara, T., Ono, T., Nogaki, F., et al. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis. Nephron Clin. Pract. 2006; 102:c35–42. Epub 2005 Sep 19.
Etanercept plus standard therapy for Wegener’s granulomatosis. N. Engl. J. Med. 2005; 352:351–361.
Booth, A., Harper, L., Hammad, T., et al. Prospective study of TNF alpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 2004; 15:717–721.
Smith, K.G., Jones, R.B., Burns, S.M., Jayne, D.R. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum. 2006; 54:2970–2982.
de Lind van Wijngaarden, R.A., Hauer, H.A., Wolterbeek, R., et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J. Am. Soc. Nephrol. 2006; 17:2264–2274. Epub 2006 Jul 6.
Rutgers, A., Slot, M., van Paassen, P., van Breda Vriesman, P., Heeringa, P., Tervaert, J.W. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am. J. Kidney Dis. 2005; 46:253–262.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jayne, D. (2008). Renal Vasculitis in the Elderly. In: MachasNúñez, J.F., Cameron, J.S., Oreopoulos, D.G. (eds) The Aging Kidney in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72659-5_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-72659-5_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-72658-8
Online ISBN: 978-0-387-72659-5
eBook Packages: MedicineMedicine (R0)